Intrinsic Value Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$923K Buy
14,427
+3,550
+33% +$233K 0.63% 35
2026
Q1
$774K Buy
10,877
+1,890
+21% +$149K 0.6% 36
2025
Q4
$737K Buy
8,987
+2,800
+45% +$218K 0.55% 38
2025
Q3
$465K Sell
6,187
-116
-2% -$8.65K 0.38% 49
2025
Q2
$467K Buy
6,303
+298
+5% +$20.7K 0.42% 45
2025
Q1
$485K Sell
6,005
-5
-0.1% -$430 0.48% 45
2024
Q4
$470K Sell
6,010
-52
-0.9% -$4.42K 0.47% 44
2024
Q3
$569K Sell
6,062
-1
-0% -$84 0.57% 36
2024
Q2
$472K Sell
6,063
-2
-0% -$163 0.49% 40
2024
Q1
$551K Sell
6,065
-40
-0.7% -$3.33K 0.59% 37
2023
Q4
$472K Sell
6,105
-641
-10% -$44.9K 0.55% 38
2023
Q3
$459K Hold
6,746
0.59% 36
2023
Q2
$548K Sell
6,746
-519
-7% -$41.4K 0.69% 35
2023
Q1
$596K Buy
+7,265
New +$519K 0.81% 31

Other funds holding GEHC

Intrinsic Value Partners's GEHC Position: Q2 2026 in Review

Intrinsic Value Partners increased its GE HealthCare (GEHC) stake by 33% in Q2 2026, buying an estimated $233K and bringing the position to 14,427 shares worth $923K. The position accounts for 0.63% of the portfolio, ranked #35.

Intrinsic Value Partners first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Intrinsic Value Partners held 14,427 shares of GE HealthCare worth $923K as of Q2 2026.
  • Intrinsic Value Partners bought 3,550 GE HealthCare shares in Q2 2026, an estimated $233K.
  • GE HealthCare made up 0.63% of Intrinsic Value Partners's portfolio in Q2 2026, its #35 holding.
  • Intrinsic Value Partners first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Intrinsic Value Partners's 13F filing for Q2 2026, filed 14 Jul 2026.